Friday 6 November 2026 Export KNSA’s income statement to Excel — free account

Kiniksa Pharmaceuticals International, plc

KNSA Healthcare Drug Manufacturers Specialty & Generic

Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024.

Revenue: +58.1%
EPS: +142.2%
Free cash flow: +43.5%

Quarter to September 2026, against a year earlier

94.14 5.80 +6.57%

Follow KNSA

Alert me

Market cap: $6.9B
P/E: 62.1×
Fwd P/E: 67.8×
Dividend yield: —
F-score: 8/9
Altman Z: 10.35
Beneish M: −3.16
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	8	8	8	8	+8 more TTM periods Free account
ROE Full definition →	17.59%	14.04%	13.74%	11.73%
ROA Full definition →	12.92%	10.36%	10.26%	8.78%
ROIC Full definition →	57.65%	48.87%	42.34%	31.44%
Return on Tangible Assets Full definition →	19.54%	16.13%	16.62%	15.13%
Average Days of Receivables Full definition →	11.88	10.20	11.24	8.40
Free Cash Flow per Share Full definition →	2.52	2.36	2.15	1.84
Free Cash Flow Full definition →	197.20	182.84	164.23	136.42
Capital Expenditures Full definition →	(1.64)	(2.13)	(1.63)	(1.57)
Other line items
Cash ROIC Full definition →	15.42%	15.49%	15.29%	13.90%
Accounts Receivable Turnover Full definition →	22.93	30.36	23.83	23.64
Accounts Payable Turnover Full definition →	18.14	8.01	6.11	38.20
Inventory Turnover Full definition →	1.25	1.44	1.69	1.91
Average Days of Payables Full definition →	16.11	52.91	110.50	9.53
Days of Inventory on Hand Full definition →	423.65	302.55	331.22	257.96
Tax Rate Full definition →	(0.25)	(0.29)	(0.31)	(0.34)
Research and Development Expense of Revenue Full definition →	14.35%	15.12%	13.93%	14.29%
Selling, General and Administrative Expense of Revenue Full definition →	26.13%	27.46%	28.37%	28.97%
Share Based Compensation of Revenue Full definition →	4.76%	5.00%	5.21%	5.46%
Operating CF/Net income Full definition →	1.81	2.29	2.27	2.34
Depreciation/Fixed assets Full definition →	0.77	0.70	0.84	0.80
Capex/Depreciation Full definition →	(0.86)	(1.19)	(0.97)	(1.01)
Revenue per Share Full definition →	12.10	10.84	9.85	9.13
Operating CF per Share Full definition →	2.54	2.38	2.17	1.86
Capex per Share Full definition →	(0.02)	(0.03)	(0.02)	(0.02)
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly